Neuropsychiatric disorders arise from complex interactions between genetic and environmental factors.DNA methylation,a reversible and environmentally responsive epigenetic regulatory mechanism,serves as a crucial brid...Neuropsychiatric disorders arise from complex interactions between genetic and environmental factors.DNA methylation,a reversible and environmentally responsive epigenetic regulatory mechanism,serves as a crucial bridge linking environmental exposure,gene expression regulation,and neurobehavioral outcomes.During long-duration deep-space missions,astronauts face multiple stressors-including microgravity,cosmic radiation,circadian rhythm disruption,and social isolation,which can induce alterations in DNA methylation and increase the risk of neuropsychiatric disorders.Genome-wide DNA methylation research can be divided into 3 major methodological stages:Study design,sample preparation and detection,and data analysis,each of which can be applied to astronaut neuropsychiatric health monitoring.Systematic comparison of the Illumina MethylationEPIC array and whole-genome bisulfite sequencing reveals their complementary strengths in terms of genomic coverage,resolution,cost,and application scenarios:the array method is cost-effective and suitable for large-scale population studies and longitudinal monitoring,whereas sequencing provides higher resolution and coverage and is more suitable for constructing detailed methylation maps and characterizing individual variation.Furthermore,emerging technologies such as single-cell methylation sequencing,nanopore long-read sequencing,and machine-learning-based multi-omics integration are expected to greatly enhance the precision and interpretability of epigenetic studies.These methodological advances provide key support for establishing DNAmethylation-based monitoring systems for neuropsychiatric risk in astronauts and lay an epigenetic foundation for safeguarding neuropsychiatric health during future long-term deep-space missions.展开更多
基金supported by the National Natural Science Foundation(81770780)the Natural Science Foundation of Hunan Province(2020JJ4901),China。
文摘目的:先天性低促性腺激素性性腺功能减退症(congenital hypogonadotropic hypogonadism,CHH)是一种罕见的先天性疾病,由于下丘脑促性腺激素释放激素的合成、分泌或信号转导缺陷引起先天性性腺发育不良。CHH以青春期发育延迟或缺乏、性激素及促性腺激素水平低下为主要表现,同时可能伴有其他临床表型。一部分CHH患者伴有嗅觉丧失或低下,被称为卡尔曼综合征(Kallmann syndrome,KS)。ANOS1基因是第一个被发现的CHH致病基因,位于X染色体上,其突变可导致X-连锁隐性遗传的CHH。本研究拟通过分析CHH患者中ANOS1的基因突变图谱以及临床表型和基因型的关系,为CHH的遗传学诊断奠定基础。方法:利用全外显子组测序(whole exome sequencing,WES)的方法筛选来自中国的165名男性CHH患者中ANOS1基因的罕见变异(rare sequencing variants,RSVs)。利用Polyphen2、Mutation tastaster、SIFT和CADD(Combined Annotation Dependent Depletion)4种常见的生物信息学工具预测编码区变异的功能,基于神经网络的剪接位点预测(Splice Site Prediction by Neural Network,NNSPLICE)软件对检测到的内含子区的RSVs进行注释,并利用美国医学遗传学和基因组学学院(American College of Medical Genetics and Genomics,ACMG)遗传变异分类标准与指南判断ANOS1 RSVs是否具有致病性。初步建立中国人群CHH患者ANOS1的遗传突变谱,通过收集部分患者详细的临床资料,建立临床表型和基因型的相关性。结果:WES分析显示165名CHH患者中17例患者发生了ANOS1突变,突变频率为10.3%。在17名CHH患者中共检测到13个ANOS1 RSVs,包括5个无义突变(p.T76X、p.R191X、p.W257X、p.R262X和p.W589X),2个剪切位点突变(c.318+3A>C和c.1063-1G>C)和6个错义突变(p.N402S、p.N155D、p.P504L、p.C157R、p.Q635P及p.V560I)。在17名携带ANOS1 RSVs的患者中,很多同时伴有其他临床表型,其中最常见的为隐睾(10/17),其次是单侧肾脏发育不全(3/17),牙齿发育不全(3/17)和联带运动(3/17)。利用ACMG对上述检测到的ANOS1 RSVs进行分析,8个RSVs包括p.T76X、p.R191X、p.W257X、p.R262X、p.W589X、c.318+3A>C、c.1063-1G>C和p.C157R被预测为致病性或可能致病性的罕见突变,且携带这些突变的患者经过临床检查全部伴随其他临床表型;然而,在携带其他被预测为非致病性(不确定性或可能良性)的ANOS1 RSVs患者中,只有1例患者同时伴随其他临床表型,且这些患者中大部分同时伴有其他CHH致病基因的RSVs。结论:初步建立了中国人群CHH患者的ANOS1基因突变谱及基因型-表型相关性。携带致病性或可能致病性ANOS1 RSV的CHH患者往往伴随其他表型。单纯非致病性ANOS1 RSV可能不足以引起CHH,但它们可能与其他CHH致病基因突变一起发挥作用,导致该疾病的发生。
基金supported by the National Natural Science Foundation(82022024)the Graduate Independent Innovation Project of Central South University(2022ZZTS0866),China.
文摘Neuropsychiatric disorders arise from complex interactions between genetic and environmental factors.DNA methylation,a reversible and environmentally responsive epigenetic regulatory mechanism,serves as a crucial bridge linking environmental exposure,gene expression regulation,and neurobehavioral outcomes.During long-duration deep-space missions,astronauts face multiple stressors-including microgravity,cosmic radiation,circadian rhythm disruption,and social isolation,which can induce alterations in DNA methylation and increase the risk of neuropsychiatric disorders.Genome-wide DNA methylation research can be divided into 3 major methodological stages:Study design,sample preparation and detection,and data analysis,each of which can be applied to astronaut neuropsychiatric health monitoring.Systematic comparison of the Illumina MethylationEPIC array and whole-genome bisulfite sequencing reveals their complementary strengths in terms of genomic coverage,resolution,cost,and application scenarios:the array method is cost-effective and suitable for large-scale population studies and longitudinal monitoring,whereas sequencing provides higher resolution and coverage and is more suitable for constructing detailed methylation maps and characterizing individual variation.Furthermore,emerging technologies such as single-cell methylation sequencing,nanopore long-read sequencing,and machine-learning-based multi-omics integration are expected to greatly enhance the precision and interpretability of epigenetic studies.These methodological advances provide key support for establishing DNAmethylation-based monitoring systems for neuropsychiatric risk in astronauts and lay an epigenetic foundation for safeguarding neuropsychiatric health during future long-term deep-space missions.
